CPAP 기기(지속적 기도양압 장치 시장 규모, 점유율, 동향 분석 보고서 : 커넥티비티별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Continuous Positive Airway Pressure Devices Market Size, Share & Trends Analysis Report By Connectivity, By End Use (Home Care Settings, Hospitals & Clinics, Others ), By Region, And Segment Forecasts, 2026 - 2033

US $ 5,950 ￦ 8,957,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,462,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,473,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

CPAP 기기(지속적 기도양압 장치 시장 요약

세계의 CPAP 기기 시장 규모는 2025년 27억 7,000만 달러로 추정되며, 2033년까지 41억 5,000만 달러에 이를 것으로 예측됩니다.

또한 2026-2033년 연평균 5.17% 성장할 것으로 예측됩니다. 수면무호흡증 유병률 증가, 예방의학에 대한 관심 증가, 신흥국 의료 인프라의 급속한 발전이 주요 요인으로 작용하고 있습니다.

정부 및 민간단체의 CPAP 장치에 대한 지원책 증가는 시장 성장을 가속할 것으로 예상되는 두드러진 추세입니다. 또한, 재택치료 솔루션과 원격 모니터링 기능에 대한 선호도가 높아지면서 시장 성장을 견인하고 있습니다. 의료시스템이 병원에서 환자의 가정으로 의료서비스 제공의 중심이 이동함에 따라, 재택 비침습적 인공호흡기 치료에서 수면무호흡증 치료기 활용에 대한 관심이 높아지고 있습니다. CPAP 장치는 기존의 병원 중심 치료에 대한 비용 효율적이고 편리한 대안을 제공하여 환자가 집에서 호흡 지원을 받을 수 있도록 도와줍니다. 재택 치료 환경에서는 환자가 익숙한 환경에서 CPAP 장치를 사용할 수 있어 편안함과 치료 순응도를 높일 수 있습니다. 이는 특히 수면무호흡증의 장기적인 관리가 필요한 분들에게 중요하며, 통원의 스트레스 없이 일상 생활에 장치를 통합할 수 있습니다.

정부 보건부와 비영리 단체들은 수면무호흡증과 그 치료의 중요성을 알리기 위한 대국민 홍보 캠페인을 자주 실시했습니다. 예를 들어, 미국에서는 질병예방통제센터(CDC)가 수면위생과 만성질환 관리에 대한 광범위한 공중보건 메시지에 수면무호흡증후군이 포함되어 있습니다. 마찬가지로 영국에서는 국민보건서비스(NHS)가 수면 건강에 대한 인식을 높이고, 수면무호흡증 진단 검사를 받으라고 권유하고 있습니다. 또한, 세계수면학회가 주최하는 '세계 수면의 날'은 수면무호흡증을 포함한 수면장애에 대한 인식을 높이기 위한 연례 세계 행사입니다. 이 행사는 언론의 큰 관심과 의료기관의 지원을 받아 CPAP 치료의 보급을 더욱 촉진하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 커넥티비티별 비즈니스 분석

제5장 최종 용도별 비즈니스 분석

제6장 지역별 추정 및 동향 분석

제7장 경쟁 구도

LSH

영문 목차

영문목차

Continuous Positive Airway Pressure Devices Market Summary

The global continuous positive airway pressure devices market size was estimated at USD 2.77 billion in 2025 and is expected to reach USD 4.15 billion by 2033, growing at a CAGR of 5.17% from 2026 to 2033. The increasing prevalence of sleep apnea, the growing emphasis on preventive healthcare, and the rapidly advancing healthcare infrastructure in emerging economies.

The rising supportive initiatives by government and private organizations for Continuous Positive Airway Pressure (CPAP) devices is a notable trend expected to fuel market growth. Furthermore, the rise in preference for home-based healthcare solutions and remote monitoring capabilities are boosting market growth. As healthcare systems shift care delivery from hospitals to patients' homes, there is a growing interest in leveraging sleep apnea devices for home-based noninvasive ventilation therapy. CPAP devices offer a cost-effective and convenient alternative to traditional hospital-based care, allowing patients to receive respiratory support in their homes. Home care settings allow patients to use CPAP devices in a familiar environment, which enhances comfort and adherence to therapy. This is particularly significant for individuals requiring long-term management of sleep apnea, as they can integrate the device into their daily routines without the stress of hospital visits.

Government Health Departments and non-profit organizations often run public awareness campaigns to educate people about sleep apnea and the importance of seeking treatment. For instance, in the U.S., the CDC has included sleep apnea in its broader public health messaging about sleep hygiene and chronic disease management. Similarly, in the UK, the National Health Service (NHS) promotes sleep health awareness and encourages people to seek diagnostic testing for sleep apnea. In addition, World Sleep Day, organized by the World Sleep Society, is an annual global event aimed at raising awareness of sleep disorders, including sleep apnea. The event garners significant media attention and support from healthcare organizations, further driving the use of CPAP therapy.

Global Continuous Positive Airway Pressure Devices Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global continuous positive airway pressure devices market report based on connectivity, end use, and region.

• Connectivity Outlook (Volume, 000'Units; Revenue, USD Million, 2021 - 2033)
• Connected
  • Bluetooth-Connected CPAP
  • Wi-Fi & Cellular Connected CPAP
  • Hybrid-Connected
• Non-Connected
• End Use Outlook (Volume, 000'Units; Revenue, USD Million, 2021 - 2033)
• Home Care Settings
• Hospitals & Clinics
• Others (Long-Term Care Facilities, etc.)
• Regional Outlook (Volume, 000'Units; Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Connectivity
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
  • 1.8.2. Volume Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidence of Obstructive Sleep Apnea (OSA)
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Supportive initiatives by government and private organizations for CPAP devices
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product recalls & failure
    • 3.2.2.2. Complex regulatory framework pertaining to CPAP devices
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growing adoption of CPAP devices in home care settings
  • 3.2.4. Pricing Analysis of CPAP Devices
  • 3.2.5. Disease Demographics
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Connectivity Business Analysis

• 4.1. Connectivity Market Share, 2025 & 2033
• 4.2. Connectivity Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Connectivity, 2021 to 2033 (USD Million) (000'Units) (000' Units)
• 4.4. Connected
  • 4.4.1. Connected market, 2021 - 2033 (USD Million) (000'Units) (000' Units)
  • 4.4.2. Bluetooth-Connected CPAP
    • 4.4.2.1. Bluetooth-connected CPAP market, 2021 - 2033 (USD Million) (000'Units) (000' Units)
  • 4.4.3. Wi-Fi & Cellular Connected CPAP
    • 4.4.3.1. Wi-Fi & cellular connected CPAP market, 2021 - 2033 (USD Million) (000'Units) (000' Units)
  • 4.4.4. Hybrid-Connected
    • 4.4.4.1. Hybrid-connected CPAP market, 2021 - 2033 (USD Million) (000'Units) (000' Units)
• 4.5. Non-Connected
  • 4.5.1. Non-connected market, 2021 - 2033 (USD Million) (000'Units) (000' Units)

Chapter 5. End Use Business Analysis

• 5.1. End Use Market Share, 2025 & 2033
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million) (000'Units)
• 5.4. Home Care Settings
  • 5.4.1. Home care settings market, 2021 - 2033 (USD Million) (000'Units)
• 5.5. Hospitals & Clinics
  • 5.5.1. Hospitals & clinics market, 2021 - 2033 (USD Million) (000'Units)
• 5.6. Others
  • 5.6.1. Others market, 2021 - 2033 (USD Million) (000'Units)

Chapter 6. Regional Estimates & Trend Analysis by Connectivity, and End Use

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 6.4. North America
  • 6.4.1. North America Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.4.2. U.S.
    • 6.4.2.1. Key country dynamic
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive insights
    • 6.4.2.4. U.S. Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.4.3. Canada
    • 6.4.3.1. Key country dynamic
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive insights
    • 6.4.3.4. Canada Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.4.4. Mexico
    • 6.4.4.1. Key country dynamic
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive insights
    • 6.4.4.4. Mexico Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
• 6.5. Europe
  • 6.5.1. Europe Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.2. UK
    • 6.5.2.1. Key country dynamic
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive insights
    • 6.5.2.4. UK Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.3. Germany
    • 6.5.3.1. Key country dynamic
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive insights
    • 6.5.3.4. Germany Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.4. France
    • 6.5.4.1. Key country dynamic
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive insights
    • 6.5.4.4. France Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.5. Italy
    • 6.5.5.1. Key country dynamic
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive insights
    • 6.5.5.4. Italy Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.6. Spain
    • 6.5.6.1. Key country dynamic
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive insights
    • 6.5.6.4. Spain Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.7. Norway
    • 6.5.7.1. Key country dynamic
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive insights
    • 6.5.7.4. Norway Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamic
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive insights
    • 6.5.8.4. Denmark Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.5.9. Sweden
    • 6.5.9.1. Key country dynamic
    • 6.5.9.2. Regulatory framework
    • 6.5.9.3. Competitive insights
    • 6.5.9.4. Sweden Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.6.2. Japan
    • 6.6.2.1. Key country dynamic
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive insights
    • 6.6.2.4. Japan Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.6.3. China
    • 6.6.3.1. Key country dynamic
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive insights
    • 6.6.3.4. China Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.6.4. India
    • 6.6.4.1. Key country dynamic
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive insights
    • 6.6.4.4. India Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamic
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive insights
    • 6.6.5.4. South Korea Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.6.6. Australia
    • 6.6.6.1. Key country dynamic
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive insights
    • 6.6.6.4. Australia Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.6.7. Thailand
    • 6.6.7.1. Key country dynamic
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive insights
    • 6.6.7.4. Thailand Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
• 6.7. Latin America
  • 6.7.1. Latin America Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.7.2. Brazil
    • 6.7.2.1. Key country dynamic
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive insights
    • 6.7.2.4. Brazil Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.7.3. Argentina
    • 6.7.3.1. Key country dynamic
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive insights
    • 6.7.3.4. Argentina Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
• 6.8. MEA
  • 6.8.1. MEA Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.8.2. South Africa
    • 6.8.2.1. Key country dynamic
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive insights
    • 6.8.2.4. South Africa Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key country dynamic
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive insights
    • 6.8.3.4. Saudi Arabia Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.8.4. UAE
    • 6.8.4.1. Key country dynamic
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive insights
    • 6.8.4.4. UAE Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key country dynamic
    • 6.8.5.2. Regulatory framework
    • 6.8.5.3. Competitive insights
    • 6.8.5.4. Kuwait Continuous Positive Airway Pressure (CPAP) devices market estimates and forecasts, 2021 - 2033 (USD Million) (000'Units)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position/Share Analysis, 2025
• 7.3. Company Categorization
• 7.4. Exit Strategies of Existing Market Players and Their Impact on Market Competitors
• 7.5. Company Profiles/Listing
  • 7.5.1. ResMed
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial performance
    • 7.5.1.3. Product benchmarking
    • 7.5.1.4. Strategic initiatives
  • 7.5.2. Koninklijke Philips N.V.
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial performance
    • 7.5.2.3. Product benchmarking
    • 7.5.2.4. Strategic initiatives
  • 7.5.3. Fisher & Paykel Healthcare Limited
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial performance
    • 7.5.3.3. Product benchmarking
    • 7.5.3.4. Strategic initiatives
  • 7.5.4. React Health (3B Medical)
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial performance
    • 7.5.4.3. Product benchmarking
    • 7.5.4.4. Strategic initiatives
  • 7.5.5. Transcend, Inc. (Somnetics International, Inc.)
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial performance
    • 7.5.5.3. Product benchmarking
    • 7.5.5.4. Strategic initiatives
  • 7.5.6. Wellell Inc. (Apex Medical)
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial performance
    • 7.5.6.3. Product benchmarking
    • 7.5.6.4. Strategic initiatives
  • 7.5.7. BMC
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial performance
    • 7.5.7.3. Product benchmarking
    • 7.5.7.4. Strategic initiatives
  • 7.5.8. Armstrong Medical (Eakin Healthcare)
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial performance
    • 7.5.8.3. Product benchmarking
    • 7.5.8.4. Strategic initiatives
  • 7.5.9. Breas Medical AB
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial performance
    • 7.5.9.3. Product benchmarking
    • 7.5.9.4. Strategic initiatives
  • 7.5.10. Sefam Medical Ltd
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial performance
    • 7.5.10.3. Product benchmarking
    • 7.5.10.4. Strategic initiatives
  • 7.5.11. Lowenstein Medical SE & Co. KG
    • 7.5.11.1. Overview
    • 7.5.11.2. Financial performance
    • 7.5.11.3. Product benchmarking
    • 7.5.11.4. Strategic initiatives
  • 7.5.12. Smith's Medical (ICU Medical, Inc.)
    • 7.5.12.1. Overview
    • 7.5.12.2. Financial performance
    • 7.5.12.3. Product benchmarking
    • 7.5.12.4. Strategic initiatives
  • 7.5.13. Trudell Healthcare Solutions Inc. (Vyaire)
    • 7.5.13.1. Overview
    • 7.5.13.2. Financial performance
    • 7.5.13.3. Product benchmarking
    • 7.5.13.4. Strategic initiatives

관련자료